• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2007年至2009年期间巴西献血者中1型和2型人类嗜T淋巴细胞病毒的血清流行率、发病率及残余输血风险

Human T-lymphotropic virus type 1 and type 2 seroprevalence, incidence, and residual transfusion risk among blood donors in Brazil during 2007-2009.

作者信息

Carneiro-Proietti Anna Bárbara F, Sabino Ester C, Leão Silvana, Salles Nanci A, Loureiro Paula, Sarr Moussa, Wright David, Busch Michael, Proietti Fernando A, Murphy Edward L

机构信息

Hemominas Foundation, Belo Horizonte, Minas Gerais, Brazil.

出版信息

AIDS Res Hum Retroviruses. 2012 Oct;28(10):1265-72. doi: 10.1089/AID.2011.0143. Epub 2012 May 3.

DOI:10.1089/AID.2011.0143
PMID:22324906
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3448098/
Abstract

Human T-lymphotropic virus type 1/2 (HTLV-1/2) infection is endemic in Brazil but representative donor prevalence and incidence data are lacking. All blood donations (2007-2009) from three blood centers in Brazil were studied. Samples reactive on one HTLV screening test (EIA) were retested with a different EIA; dual EIA reactivity correlated strongly with a confirmatory Western blot. Prevalence, incidence, and residual transfusion risk were calculated. Among 281,760 first-time donors, 363 were positive for HTLV on both EIAs (135 per 10(5), 95% CI 122-150). Prevalence differed considerably by region, from 83 to 222 per 10(5). Overall incidence rate was 3.6/10(5) person-years and residual transfusion risk was 5.0/10(6) per blood unit transfused. The logistic regression model showed significant associations with: age [adjusted odds ratio (aOR)=5.23 for age 50+ vs. <20], female sex (aOR=1.97), black (aOR=2.70 vs. white), and mixed skin colors (aOR=1.78 vs. white), and inversely with education (aOR=0.49, college vs. less than high school). HTLV testing with a dual-EIA strategy is feasible and can be useful in areas with low resources. Incidence and residual risk of HTLV-1 transmission by transfusion were relatively high and could be reduced by improving donor recruitment and selection in high prevalence areas. Blood center data may contribute to surveillance for HTLV infection.

摘要

人类嗜T淋巴细胞病毒1型/2型(HTLV - 1/2)感染在巴西呈地方性流行,但缺乏具有代表性的献血者感染率和发病率数据。对巴西三个血液中心2007年至2009年的所有献血进行了研究。在一项HTLV筛查试验(酶免疫测定,EIA)中呈反应性的样本,用另一种不同的EIA进行复测;双重EIA反应性与确证性免疫印迹法密切相关。计算了感染率、发病率和残余输血风险。在281,760名首次献血者中,两种EIA检测HTLV均呈阳性的有363人(每10⁵人中135人,95%置信区间122 - 150)。不同地区的感染率差异很大,每10⁵人中从83人到222人不等。总体发病率为3.6/10⁵人年,每输注一个血液单位的残余输血风险为5.0/10⁶。逻辑回归模型显示与以下因素有显著关联:年龄[50岁及以上与20岁以下相比,调整后的优势比(aOR)=5.23]、女性(aOR = 1.97)、黑人(与白人相比,aOR = 2.70)、混合肤色(与白人相比,aOR = 1.78),与受教育程度呈负相关(大学学历与高中以下学历相比,aOR = 0.49)。采用双重EIA策略进行HTLV检测是可行的,在资源匮乏地区可能有用。通过输血传播HTLV - 1的发病率和残余风险相对较高,可通过改善高流行地区的献血者招募和筛选来降低。血液中心的数据可能有助于HTLV感染的监测。

相似文献

1
Human T-lymphotropic virus type 1 and type 2 seroprevalence, incidence, and residual transfusion risk among blood donors in Brazil during 2007-2009.2007年至2009年期间巴西献血者中1型和2型人类嗜T淋巴细胞病毒的血清流行率、发病率及残余输血风险
AIDS Res Hum Retroviruses. 2012 Oct;28(10):1265-72. doi: 10.1089/AID.2011.0143. Epub 2012 May 3.
2
Human T-cell lymphotropic virus type I and II seroprevalence among volunteer blood donors in Thailand.泰国献血者中人类 T 细胞嗜淋巴细胞病毒 I 型和 II 型的血清流行率。
Pathog Glob Health. 2018 Oct;112(7):343-348. doi: 10.1080/20477724.2018.1541576. Epub 2018 Nov 14.
3
Seroprevalence of human T lymphotropic virus antibodies among healthy blood donors at a tertiary centre in Lagos, Nigeria.尼日利亚拉各斯一家三级医疗中心健康献血者中人类嗜T淋巴细胞病毒抗体的血清流行率。
Pan Afr Med J. 2014 Apr 21;17:301. doi: 10.11604/pamj.2014.17.301.4075. eCollection 2014.
4
Seroprevalence of Human T-Cell Lymphotropic Virus-1/2 in Blood Donors in Northern Pakistan: Implications for Blood Donor Screening.巴基斯坦北部献血者中人类嗜T细胞病毒1/2型的血清流行率:对献血者筛查的启示
J Coll Physicians Surg Pak. 2015 Dec;25(12):874-7.
5
Human T-Lymphotropic Virus Type 1 and 2 Seroprevalence among first-time blood donors in Chile, 2011-2013.2011-2013 年智利首次献血者中人类 T 淋巴细胞病毒 1 型和 2 型的血清流行率。
J Med Virol. 2016 Jun;88(6):1067-75. doi: 10.1002/jmv.24428. Epub 2015 Nov 18.
6
The prevalence of human T-cell leukemia virus in blood donors in China.中国献血者中人类 T 细胞白血病病毒的流行率。
Transfusion. 2019 Jul;59(7):2361-2367. doi: 10.1111/trf.15309. Epub 2019 Apr 15.
7
[Investigation of anti-HTLV I/II seroprevalence in healthy blood donors in Izmir region, Turkey].[土耳其伊兹密尔地区健康献血者中抗人嗜T淋巴细胞病毒I/II血清阳性率的调查]
Mikrobiyol Bul. 2010 Oct;44(4):579-84.
8
Seroprevalence of HTLV-I/II in blood donors in Monterrey, Mexico.墨西哥蒙特雷献血者中人类嗜T淋巴细胞病毒I/II型的血清阳性率。
Arch Med Res. 1996 Spring;27(1):97-9.
9
Seroprevalence of HTLV-1/2 Among Voluntary Blood Donors in Vietnam.越南无偿献血者中人类嗜T淋巴细胞病毒1型/2型的血清流行率
AIDS Res Hum Retroviruses. 2019 Apr;35(4):376-381. doi: 10.1089/AID.2018.0240. Epub 2019 Jan 29.
10
Heterogeneous geographic distribution of human T-cell lymphotropic viruses I and II (HTLV-I/II): serological screening prevalence rates in blood donors from large urban areas in Brazil.人类嗜T细胞病毒I型和II型(HTLV-I/II)的异质性地理分布:巴西大城市地区献血者的血清学筛查患病率
Cad Saude Publica. 2005 May-Jun;21(3):926-31. doi: 10.1590/s0102-311x2005000300027. Epub 2005 May 2.

引用本文的文献

1
Multicenter cross-sectional study of HTLV-1 prevalence and associated risk factors in epidemiologically relevant groups across Brazil.巴西不同流行病学相关群体中人类嗜T淋巴细胞病毒1型(HTLV-1)流行率及相关危险因素的多中心横断面研究。
Front Public Health. 2025 Mar 3;13:1511374. doi: 10.3389/fpubh.2025.1511374. eCollection 2025.
2
How do socioeconomic determinants of health affect the likelihood of living with HTLV-1 globally? A systematic review with meta-analysis.健康的社会经济决定因素如何影响全球 HTLV-1 感染者的生存概率?一项系统评价和荟萃分析。
Front Public Health. 2024 Jan 24;12:1298308. doi: 10.3389/fpubh.2024.1298308. eCollection 2024.
3
Blood Center Testing Allows the Detection and Rapid Treatment of Acute and Recent HIV Infection.血站检测可发现并快速治疗急性和近期 HIV 感染。
Viruses. 2022 Oct 23;14(11):2326. doi: 10.3390/v14112326.
4
Multi-Epitope Protein as a Tool of Serological Diagnostic Development for HTLV-1 and HTLV-2 Infections.多表位蛋白作为 HTLV-1 和 HTLV-2 感染血清学诊断开发的工具。
Front Public Health. 2022 May 23;10:884701. doi: 10.3389/fpubh.2022.884701. eCollection 2022.
5
Prevalence and Risk Factors for Human T-Cell Lymphotropic Virus (HTLV) in Blood Donors in Brazil-A 10-Year Study (2007-2016).巴西献血者中人类嗜T细胞病毒(HTLV)的流行率及危险因素——一项为期10年的研究(2007 - 2016年)
Front Med (Lausanne). 2022 Mar 9;9:844265. doi: 10.3389/fmed.2022.844265. eCollection 2022.
6
Brazilian Protocol for Sexually Transmitted Infections 2020: human T-cell lymphotropic virus (HTLV) infection.《2020年巴西性传播感染防治方案:人类嗜T淋巴细胞病毒(HTLV)感染》
Rev Soc Bras Med Trop. 2021 May 17;54(suppl 1):e2020605. doi: 10.1590/0037-8682-605-2020. eCollection 2021.
7
Seroprevalence and Trends of HTLV-1/2 among Blood Donors of Santo Domingo, Dominican Republic, 2012-2017.2012-2017 年多米尼加共和国圣多明各献血者中 HTLV-1/2 的血清流行率和趋势。
Rev Esp Quimioter. 2021 Feb;34(1):44-50. doi: 10.37201/req/117.2020. Epub 2020 Dec 11.
8
10-year analysis of human immunodeficiency virus incidence in first-time and repeat donors in Brazil.巴西首次和重复献血者人类免疫缺陷病毒感染率的 10 年分析。
Vox Sang. 2021 Feb;116(2):207-216. doi: 10.1111/vox.13002. Epub 2020 Sep 30.
9
Lymphotropic Viruses EBV, KSHV and HTLV in Latin America: Epidemiology and Associated Malignancies. A Literature-Based Study by the RIAL-CYTED.拉丁美洲的嗜淋巴细胞病毒EBV、KSHV和HTLV:流行病学及相关恶性肿瘤。RIAL-CYTED基于文献的研究
Cancers (Basel). 2020 Aug 4;12(8):2166. doi: 10.3390/cancers12082166.
10
High prevalence of human T-cell leukemia virus type-1b genotype among blood donors in Gabon, Central Africa.高流行率的人类 T 细胞白血病病毒 1b 型基因型在加蓬,中非的献血者中。
Transfusion. 2020 Jul;60(7):1483-1491. doi: 10.1111/trf.15838. Epub 2020 May 15.

本文引用的文献

1
Epidemiology, treatment, and prevention of human T-cell leukemia virus type 1-associated diseases.人类 T 细胞白血病病毒 1 型相关疾病的流行病学、治疗和预防。
Clin Microbiol Rev. 2010 Jul;23(3):577-89. doi: 10.1128/CMR.00063-09.
2
Increased all-cause and cancer mortality in HTLV-II infection.人类嗜 T 淋巴细胞病毒 II 型感染导致全因和癌症死亡率增加。
J Acquir Immune Defic Syndr. 2010 Jul;54(3):290-6. doi: 10.1097/QAI.0b013e3181cc5481.
3
Evaluation of the use of real-time PCR for human T cell lymphotropic virus 1 and 2 as a confirmatory test in screening for blood donors.评价实时聚合酶链反应在人 T 细胞嗜淋巴细胞病毒 1 和 2 作为献血者筛查的确认试验中的应用。
Rev Soc Bras Med Trop. 2010 Mar-Apr;43(2):111-5. doi: 10.1590/s0037-86822010000200001.
4
Demographic profile of blood donors at three major Brazilian blood centers: results from the International REDS-II study, 2007 to 2008.巴西三大血站献血者人口学特征:2007-2008 年国际 REDS-II 研究结果。
Transfusion. 2010 Apr;50(4):918-25. doi: 10.1111/j.1537-2995.2009.02529.x. Epub 2009 Dec 10.
5
Blood donor deferral in Minas Gerais State, Brazil: blood centers as sentinels of urban population health.巴西米纳斯吉拉斯州的献血者延期:血站作为城市人口健康的哨兵
Transfusion. 2009 May;49(5):851-7. doi: 10.1111/j.1537-2995.2008.02062.x. Epub 2009 Jan 2.
6
Residual infectious disease risk in screened blood transfusion from a high-prevalence population: Santa Catarina, Brazil.来自高流行率人群的筛查输血中的残余传染病风险:巴西圣卡塔琳娜州
Transfusion. 2008 Feb;48(2):273-81. doi: 10.1111/j.1537-2995.2007.01521.x. Epub 2007 Nov 13.
7
Difficulties in the diagnosis of HTLV-2 infection in HIV/AIDS patients from Brazil: comparative performances of serologic and molecular assays, and detection of HTLV-2b subtype.巴西艾滋病患者中人类嗜T淋巴细胞病毒2型(HTLV - 2)感染的诊断困难:血清学和分子检测方法的比较性能以及HTLV - 2b亚型的检测
Rev Inst Med Trop Sao Paulo. 2007 Jul-Aug;49(4):225-30. doi: 10.1590/s0036-46652007000400006.
8
HTLV in the Americas: challenges and perspectives.美洲的人类嗜T淋巴细胞病毒:挑战与展望
Rev Panam Salud Publica. 2006 Jan;19(1):44-53. doi: 10.1590/s1020-49892006000100007.
9
Global epidemiology of HTLV-I infection and associated diseases.人类嗜T淋巴细胞病毒I型(HTLV-I)感染及其相关疾病的全球流行病学
Oncogene. 2005 Sep 5;24(39):6058-68. doi: 10.1038/sj.onc.1208968.
10
Heterogeneous geographic distribution of human T-cell lymphotropic viruses I and II (HTLV-I/II): serological screening prevalence rates in blood donors from large urban areas in Brazil.人类嗜T细胞病毒I型和II型(HTLV-I/II)的异质性地理分布:巴西大城市地区献血者的血清学筛查患病率
Cad Saude Publica. 2005 May-Jun;21(3):926-31. doi: 10.1590/s0102-311x2005000300027. Epub 2005 May 2.